ArticlePharmacoEconomics2017
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK.
C Rinciog et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it
ArticlePharmacoEconomics2017
C Rinciog et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.